=== Ticker Info ===
address1	No.167, Fuxing North Road
address2	Floor 5-1
city	Taipei
zip	104
country	Taiwan
phone	886 2 2545 3697
fax	886 2 2514 0245
website	https://www.phytohealth.com.tw
industry	Drug Manufacturers - Specialty & Generic
industryKey	drug-manufacturers-specialty-generic
industryDisp	Drug Manufacturers - Specialty & Generic
sector	Healthcare
sectorKey	healthcare
sectorDisp	Healthcare
longBusinessSummary	PhytoHealth Corporation researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and dietary supplements in Taiwan. The company operates in three segments: Pharmaceutical Drugs and Dietary Supplement, Medical Diagnostic Products, and Precision Medical Equipment. The Pharmaceutical Drugs and Dietary Supplement segment manufactures and sells Chinese medicine and new pharmaceutical products. The Medical Diagnostic Products segment develops and sells smart medical imaging diagnostic products device. The Precision Medical Equipment segment engages in the research and development, manufacturing, and sale of ultrasonic probes. The company's products under development include PHN031, which has completed Phase II clinical trials for the treatment of osteoporosis; and PHN033, which has completed Phase II clinical trials for the treatment of diabetic nephropathy. It is also developing PHN016 that is in Phase II clinical trials for the treatment of cancer; and PHN017 for the treatment of severe infection-induced cytokine storm and is in phase I trial. In addition, the company offers PG2 Lyophilized injection for the treatment of cancer related fatigue; and capsules. It has collaboration agreement with Indena S.P.A for the development of botanical extracts. PhytoHealth Corporation was incorporated in 1998 and is based in Taipei, Taiwan.
companyOfficers	[{'maxAge': 1, 'name': 'Ms. Yi-Li  Lee', 'title': 'Chairman', 'fiscalYear': 2022, 'totalPay': 2448000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'I-Lin  Lee', 'title': 'President & Director', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Chih Yuan  Huang', 'title': 'Financial & Accounting Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Kevin  Lin', 'title': 'Manager of Administration Division', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Fred  Lai', 'title': 'Managing Director', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Li Feng  Yeh', 'title': 'Chief Internal Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate	1672444800
maxAge	86400
priceHint	2
previousClose	19.6
open	19.7
dayLow	19.5
dayHigh	19.8
regularMarketPreviousClose	19.6
regularMarketOpen	19.7
regularMarketDayLow	19.5
regularMarketDayHigh	19.8
beta	1.007
volume	124399
regularMarketVolume	124399
averageVolume	330609
averageVolume10days	162798
averageDailyVolume10Day	162798
bid	19.65
ask	19.7
marketCap	3912794624
fiftyTwoWeekLow	19.2
fiftyTwoWeekHigh	25.25
priceToSalesTrailing12Months	24.080368
fiftyDayAverage	20.511
twoHundredDayAverage	21.15075
currency	TWD
enterpriseValue	3077839616
profitMargins	-0.28997
sharesOutstanding	198619008
heldPercentInsiders	0.24746999
heldPercentInstitutions	0.00423
impliedSharesOutstanding	203724992
bookValue	9.703
priceToBook	2.0303
lastFiscalYearEnd	1703980800	 (2023-12-31 08:00:00)
nextFiscalYearEnd	1735603200	 (2024-12-31 08:00:00)
mostRecentQuarter	1703980800	 (2023-12-31 08:00:00)
netIncomeToCommon	-47117000
trailingEps	-0.34
enterpriseToRevenue	18.942
enterpriseToEbitda	-38.882
52WeekChange	-0.048309207
SandP52WeekChange	0.26265144
exchange	TAI
quoteType	EQUITY
symbol	4108.TW
underlyingSymbol	4108.TW
shortName	PHYTOHEALTH CORP.
longName	PhytoHealth Corporation
firstTradeDateEpochUtc	1216170000	 (2008-07-16 09:00:00)
timeZoneFullName	Asia/Taipei
timeZoneShortName	CST
uuid	080e73c0-9141-3c61-98b9-270ad731db5d
messageBoardId	finmb_12961651
gmtOffSetMilliseconds	28800000
currentPrice	19.7
recommendationKey	none
totalCash	1266096000
totalCashPerShare	6.374
ebitda	-79158000
totalDebt	28002000
quickRatio	23.191
currentRatio	26.133
totalRevenue	162488992
debtToEquity	1.233
revenuePerShare	0.818
returnOnAssets	-0.03226
returnOnEquity	-0.03261
freeCashflow	-58462124
operatingCashflow	-54772000
revenueGrowth	0.378
grossMargins	0.41629001
ebitdaMargins	-0.48716
operatingMargins	-0.90655
financialCurrency	TWD
trailingPegRatio	None

=== Financials ===
                                                             2023-12-31   2022-12-31   2021-12-31   2020-12-31
Tax Effect Of Unusual Items                                         0.0          0.0          0.0     -19800.0
Tax Rate For Calcs                                                  0.0          0.0          0.0          0.2
Normalized EBITDA                                           -20698000.0  -62022000.0  -42396000.0  -61030000.0
Total Unusual Items                                                 0.0      50000.0      99000.0     -99000.0
Total Unusual Items Excluding Goodwill                              0.0      50000.0      99000.0     -99000.0
Net Income From Continuing Operation Net Minority Interest  -47117000.0  -79413000.0  -77715000.0  -88242000.0
Reconciled Depreciation                                      53105000.0   52439000.0   52814000.0   54891000.0
Reconciled Cost Of Revenue                                   94846000.0   78433000.0   90623000.0   46307000.0
EBITDA                                                      -20698000.0  -61972000.0  -42297000.0  -61129000.0
EBIT                                                        -73803000.0 -114411000.0  -95111000.0 -116020000.0
Net Interest Income                                          18053000.0   11847000.0    8421000.0    5522000.0
Interest Expense                                               344000.0     312000.0     405000.0     240000.0
Interest Income                                              18397000.0   12159000.0    8826000.0    5762000.0
Normalized Income                                           -47117000.0  -79463000.0  -77814000.0  -88162800.0
Net Income From Continuing And Discontinued Operation       -47117000.0  -79413000.0  -77715000.0  -88242000.0
Total Expenses                                              284166000.0  292179000.0  301143000.0  262148000.0
Diluted Average Shares                                      198619000.0  198619000.0  195702000.0  163617000.0
Basic Average Shares                                        198619000.0  198619000.0  195702000.0  163617000.0
Diluted EPS                                                       -0.24         -0.4         -0.4        -0.54
Basic EPS                                                         -0.24         -0.4         -0.4        -0.54
Diluted NI Availto Com Stockholders                         -47117000.0  -79413000.0  -77715000.0  -88242000.0
Net Income Common Stockholders                              -47117000.0  -79413000.0  -77715000.0  -88242000.0
Otherunder Preferred Stock Dividend                                 0.0          0.0          0.0          0.0
Net Income                                                  -47117000.0  -79413000.0  -77715000.0  -88242000.0
Minority Interests                                           27030000.0   35310000.0   17801000.0   30413000.0
Net Income Including Noncontrolling Interests               -74147000.0 -114723000.0  -95516000.0 -118655000.0
Net Income Continuous Operations                            -74147000.0 -114723000.0  -95516000.0 -118655000.0
Tax Provision                                                       0.0          0.0          0.0    2395000.0
Pretax Income                                               -74147000.0 -114723000.0  -95516000.0 -116260000.0
Other Non Operating Income Expenses                          29477000.0   30094000.0   28171000.0   48655000.0
Special Income Charges                                              0.0      50000.0      99000.0     -99000.0
Write Off                                                           0.0     -50000.0     -99000.0      99000.0
Net Non Operating Interest Income Expense                    18053000.0   11847000.0    8421000.0    5522000.0
Interest Expense Non Operating                                 344000.0     312000.0     405000.0     240000.0
Interest Income Non Operating                                18397000.0   12159000.0    8826000.0    5762000.0
Operating Income                                           -121677000.0 -156714000.0 -132207000.0 -170338000.0
Operating Expense                                           189320000.0  213746000.0  210520000.0  215841000.0
Research And Development                                     92594000.0  119521000.0  120465000.0  124723000.0
Selling General And Administration                           96726000.0   94225000.0   90055000.0   91118000.0
Selling And Marketing Expense                                35667000.0   32876000.0   27291000.0   29442000.0
General And Administrative Expense                           61059000.0   61349000.0   62764000.0   61676000.0
Gross Profit                                                 67643000.0   57032000.0   78313000.0   45503000.0
Cost Of Revenue                                              94846000.0   78433000.0   90623000.0   46307000.0
Total Revenue                                               162489000.0  135465000.0  168936000.0   91810000.0
Operating Revenue                                           162489000.0  135465000.0  168936000.0   91810000.0